Treatment Database
Recombinant fully human IgG1 monoclonal antibody targeted to the Zaire ebolavirus glycoprotein
Trade Name not avaiable
Orphan Indication Ebola Virus Disease
USA Market Approval
USA Designation Date 08-05-2019
Sponsor Ridgeback Biotherapeutics, LP
3162 Commodore Plaza, Suite 3E
Coconut Grove, Florida, 33133
More about Ebola
Free Newsletter
Related Videos